Abstract 3154: Outcomes after progression of disease with anti-PD-1/PDL1 therapy for advanced melanoma
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Research"
DOI: 10.1158/1538-7445.am2020-3154
Abstract: Purpose:Antibodies blocking programmed death-1 receptor (anti-PD-1) produce durable responses in patients with metastatic melanoma, although >50% of patients ultimately experience disease progression. We aimed to identify prognostic factors and outcomes to subsequent therapies in patients… read more here.
Keywords: advanced melanoma; disease; progression disease; outcomes progression ... See more keywords